About this trial
The goal of this clinical study is to gain further insights into the treatment of patients with Low Anterior Resection Syndrome (LARS) symptoms after rectal resection. The main question is: Can LARS symptoms and quality of life be improved by implementing an intensified follow-up program? Researchers will compare the results of the intervention group with the results of a control group in which patients do not receive an intensified follow-up program to determine whether the intervention works. Participants will undergo an intensified follow-up program which consists of several follow-up visits and medical treatment, pelvic floor muscle training and gynaecological and urological co-treatment in case of LARS symptoms and urinary or sexual complaints.
Eligibility criteria
Qualifiers
patients older than 18 years
patients with rectal cancer in the middle and lower third of the rectum in stages I to IV who underwent LAR with TME and protective ileostomy
able to give informed consent as documented by signature
Disqualifiers
dementia or other psychiatric disorder that would prevent the patients from answering the questionnaires and experiencing sustainable training effects
impossibility of stoma reversal due to persistent anastomotic leak and/or local recurrence
Trial design
Treatments tested in this trial
- Intensified follow-up program
Treatment groups
Sponsors and collaborators
University Hospital, Basel, Switzerland
Lead sponsor
St. Claraspital AG
Collaborator
Clarunis - Universitäres Bauchzentrum Basel
Collaborator